Oracle's (NYSE: ORCL) stock price jumped 9.2% on March 11 in response to its third-quarter fiscal 2026 earnings and updated guidance. But the stock is still down big year to date and is over 50% off ...

Oracle surpassed estimates for the quarter, and lifted its guidance for fiscal 2027 revenue. During the quarter, Oracle announced plans to raise $45 billion to $50 billion in the fiscal year to expand ...

Oracle landed more contracts and guided for massive growth in its upcoming fiscal year. The company understands that its cash burn is unsustainable. Oracle’s balance sheet has gone from bad to worse.

As I write this, nine American companies have a market capitalization of $1 trillion or more. Most of them are from the technology and technology-adjacent sectors, which are generating phenomenal ...

Oracle ORCL0.79%increase; green up pointing triangle will spend $500 million more on restructuring costs in the current fiscal year than previously reported as artificial-intelligence models allow the ...

On Oracle's earnings call, CEO Clay Magouyrk named Cerebras as an important maker of artificial intelligence hardware, alongside Nvidia and AMD. Landing Oracle as a customer could be a big boon for ...

Oracle Corp. shares soared as much as 15% on Wednesday after the software and cloud services company reported strong sales and issued an outlook that suggests little letup in demand for AI computing.

Oracle is building data centers that essentially rent chips to companies looking to run artificial intelligence solutions. Oracle's backlog is heavily dependent on a multi-year, ...

Oracle landed more contracts and guided for massive growth in its upcoming fiscal year. The company understands that its cash burn is unsustainable. Oracle’s balance sheet has gone from bad to worse.

Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.